Warning Issued Over Mounjaro Weight Loss Medications

As the UK's obesity crisis deepens, experts are sounding the alarm over a "common mistake" in prescribing Mounjaro, a slimming injection available on the NHS. A nurse has warned that thousands of patients could be at risk of life-threatening organ failure due to a lack of mandatory blood screening. The Medicines and Healthcare products Regulatory Agency (MHRA) is investigating reports of pancreatitis linked to GLP-1 drugs like Mounjaro, Ozempic, and Wegovy, with over 560 reports and 10 deaths. Meanwhile, genetic screening is being explored as a way to make prescribing safer in the future.

Key Takeaways:

• A nurse has warned that thousands of patients taking Mounjaro may be at risk of life-threatening organ failure due to a lack of mandatory blood screening.
• Experts believe high fat levels, combined with dehydration and other factors, could make certain people more vulnerable to pancreatitis, a condition that can trigger organ failure and even prove fatal in severe cases.
• People with uncontrolled diabetes are also at greater risk of becoming severely dehydrated, which can be very serious.
• Adverse drug reactions already cost the NHS an estimated £2.2 billion a year in hospital stays alone, and account for one in six hospital admissions.
• Genetic testing could prevent almost a third of side effects to medicines.
• Mounjaro has been linked to side effects such as nausea, diarrhoea, and dehydration, which can lead to headaches, dizziness, and, in rare cases, seizures or kidney failure if untreated.
• Around 1.5 million people in the UK are thought to be using weight loss jabs, with many paying privately as NHS supplies remain limited.
• The main warning sign of pancreatitis is severe stomach pain radiating to the back that doesn't go away, and anyone experiencing this is urged to seek urgent medical attention.

Statistics:

• Over 560 reports of pancreatitis linked to GLP-1 drugs have been reported to the MHRA since their launch.
• 10 deaths have been linked to pancreatitis caused by GLP-1 drugs.
• Almost a third of side effects to medicines could be prevented with genetic testing.
• Adverse drug reactions already cost the NHS an estimated £2.2 billion a year in hospital stays alone.
• 1.5 million people in the UK are thought to be using weight loss jabs.

Sources:

• Mail Online
• Medicines and Healthcare products Regulatory Agency (MHRA)
• Genomics England
• Bloomberg via Getty Images
• Reuters